Ventas (VTR) Akcie Kurz
Ventas Kurz
Tržby rostly o 14,9 % ročně za posledních 19 let na 5,83 Mld. USD. Zisk na akcii klesal o 4,4 % ročně za posledních 19 let. čistá marže společnosti Ventas je nyní 4,3 %, nahoru z 1,3 % před několika lety. Ventas aktuálně nabízí dividendový výnos kolem 2,20 %. Výplatní poměr je kolem 367 % zisku. Dividenda rostla o 1,0 % ročně za posledních 19 let. Medián cílové ceny analytiků je 99,00 USD, tedy nad aktuální cenu o 13,5 %. Z 27 analytiků jich 22 doporučuje nákup — celkový konsenzus je Koupit.
Cena akcie Ventas
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Ventas a analýza akcií
Nejčastější otázky týkající se akcie Ventas
Ventas Inc is a leading real estate investment trust (REIT) specializing in healthcare properties. The business model of Ventas Inc revolves around owning, operating, and acquiring a diversified portfolio of properties across the healthcare sector. Their primary focus is on leasing and managing healthcare facilities, including senior housing communities, medical offices, hospitals, and research centers. By providing essential real estate solutions to healthcare providers, Ventas Inc generates recurring rental income and long-term value for its shareholders. Through strategic investments and a commitment to innovation, Ventas Inc continues to contribute to the growth and development of the healthcare industry.
Ventas Inc is primarily active in the healthcare real estate sector.
Some of the main competitors of Ventas Inc in the market include Welltower Inc and HCP Inc.
Ventas Inc is a renowned company operating in the real estate investment trust (REIT) sector. Established in 1998 and headquartered in Chicago, Illinois, Ventas specializes in healthcare-related properties. They own and manage a diverse portfolio of premium healthcare facilities, including senior housing communities, medical office buildings, hospitals, and skilled nursing facilities. Ventas has played a pivotal role in transforming the healthcare real estate sector through its strategic acquisitions and investments. With a strong commitment to delivering exceptional care environments, Ventas Inc has become a leading name in the industry, offering investors an opportunity to participate in this thriving sector.
Some significant milestones achieved by Ventas Inc include becoming the first healthcare real estate investment trust (REIT) to be listed on the New York Stock Exchange in 1999. The company also expanded its portfolio through strategic acquisitions, such as the $7.2 billion merger with Nationwide Health Properties in 2011. Additionally, Ventas Inc consistently demonstrated strong financial performance, increasing its annual dividend for 19 consecutive years. The company's commitment to long-term growth and its focus on providing quality healthcare real estate solutions have made Ventas Inc a leader in the industry.
Ventas Inc is primarily present in the United States.
Ventas Inc represents a commitment to integrity, innovation, and excellence in the healthcare real estate industry. The company strives to enhance the lives of seniors and other patients by providing high-quality and transformative healthcare environments. With a focus on sustainable growth and generating long-term value for stakeholders, Ventas Inc employs a philosophy of collaboration, transparency, and ethical business practices. By consistently delivering innovative solutions and maintaining strong relationships with its tenants and partners, Ventas Inc continues to lead the way in the healthcare real estate sector.
Analytici aktuálně stanovují průměrnou cílovou cenu 98,85 USD pro akcii Ventas (medián: 99,00 USD), tedy +13,8 % vůči poslední ceně. Konsensus vychází z 27 hodnocení analytiků.
27 analytiků aktuálně hodnotí akcii Ventas: 22 doporučuje koupit, 5 držet a 0 prodat. Pro rok 2026 analytici očekávají u Ventas tržby 6,94 Mld. USD a zisk na akcii 0,57 USD.
Při aktuálním kurzu se akcie Ventas obchoduje za 78,00 EUR (87,26 USD).
Akcie Ventas (VTR) je kótována na 7 burzách, mimo jiné: NYSE (VTR), London (0LO4.L), SIX (Zürich) (VEN.SW), Frankfurt (VEN.F), München (VEN.MU), Düsseldorf (VEN.DU).
Ventas Inc is a US-based company specializing in healthcare real estate investments. Its business model is based on acquiring and managing properties used by healthcare and senior living facilities. The company is divided into three business segments: Senior Housing Operating Portfolio (SHOP), Medical Office Buildings (MOB), and Life Science Properties (LSP). SHOP includes a wide range of nursing homes and elderly care facilities. Ventas Inc acquires these properties either through facility purchases or by acquiring concession contracts from operators. The company directly operates approximately 110 facilities, making SHOP its highest revenue-generating segment. The MOB segment focuses on acquiring properties used by medical facilities such as doctor's offices, laboratories, and surgical centers. These facilities are often located in complex buildings or campus-like environments and often offer services such as pharmacies, radiology, and rehabilitation. LSP focuses on the real estate needs of life science companies, including biopharmaceutical, biotechnology, and diagnostic companies. The complexity of the properties developed for life science companies requires a high level of expertise and flexibility. Ventas Inc also provides financing and capital structures for the development or acquisition of properties in the SHOP, MOB, and LSP segments. These financing offerings can be tailored to the specific needs of facilities and operators and also include partnerships with other investors. Ventas Inc strives to ensure high-quality and continuous care for patients in its healthcare market through the provision of real estate and financing. The company also emphasizes a long-term growth strategy focused on strengthening operational performance and financial metrics. Overall, Ventas Inc's business model demonstrates a consistent focus on the increasingly important healthcare industry and the needs of patients. With a wide range of real estate offerings and financing options, the company is well-positioned to drive industry growth.
Tržby očekávané za Ventas činí 6,94 Mld. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk očekávané za Ventas činí 272,74 Mil. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Ventas je aktuálně 153,81. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Ventas.
Poměr ceny k tržbám (P/S) Ventas je aktuálně 6,05. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Ventas.
Score kvality pro Ventas je 4/10.
ISIN Ventas je US92276F1003. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Ventas je 878380. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Ventas je VTR. Symbol tickeru se používá k obchodování akcií Ventas na burze.
Ventas akcie
Ventas Peer Group
Ventas Ticker
Ventas FIGI
Všechny fundamentální údaje o Ventas v podrobné analýze
Naše analýzy akcií společnosti Ventas zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Ventas. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: